Company intelligence / Profile preview

DoMore Diagnostics

Oslo, Oslo County, Norwaydomorediagnostics.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

The company’s CE-marked AI algorithm provides objective and precise prognostic information from digital H&E-stained tumor slides in colorectal cancer. Published results show the technology outperforms existing markers and can guide therapy selection to reduce over-/undertreatment. Results have appeared in high-impact journals such as The Lancet and Nature Reviews Cancer. Additional clinical validation ongoing.

Therapeutic areas: Oncology
Modalities: Device (AI-based diagnostic software)Non-pharmacological therapy (digital biomarker/diagnostic)Artificial intelligence algorithm (for digital pathology)
Industry: Pathology

Drug pipeline

1 asset

Histotype Px Colorectal

Commercial

Indications: Colorectal cancer

Partnerships

Collaborations with Oslo University HospitalUniversity of OxfordUniversity College Londonongoing collaborations with research groups in Europe, Japan, Australia

Beyond the preview

Go deeper on DoMore Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DoMore Diagnostics.

Explore the full profile